# Timothy A. Chan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/timothy-a-chan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 104,669 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 130 |
| i10-index | 274 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5080223712 |
| ORCID iD | https://orcid.org/0000-0002-9265-0283 |
| Works | 1,077 |

## Researcher papers

- [Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer](https://scholariq.org/papers/mutational-landscape-determines-sensitivity-to-pd-1-blockade-in-non-small-cell/)
- [Tumor mutational load predicts survival after immunotherapy across multiple cancer types](https://scholariq.org/papers/tumor-mutational-load-predicts-survival-after-immunotherapy-across-multiple/)
- [Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade](https://scholariq.org/papers/clonal-neoantigens-elicit-t-cell-immunoreactivity-and-sensitivity-to-immune/)
- [Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic](https://scholariq.org/papers/development-of-tumor-mutation-burden-as-an-immunotherapy-biomarker-utility-for/)
- [Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy](https://scholariq.org/papers/patient-hla-class-i-genotype-influences-cancer-response-to-checkpoint-blockade/)
- [Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies](https://scholariq.org/papers/somatic-mutations-of-the-parkinson-s-disease-associated-gene-park2-in/)
- [Integrated genomic characterization of IDH1-mutant glioma malignant progression](https://scholariq.org/papers/integrated-genomic-characterization-of-idh1-mutant-glioma-malignant-progression/)
- [Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy](https://scholariq.org/papers/mutations-in-brca1-and-brca2-differentially-affect-the-tumor-microenvironment/)
- [Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma](https://scholariq.org/papers/genetic-hallmarks-of-recurrent-metastatic-adenoid-cystic-carcinoma/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.